🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cancer risk associated with cytomegalovirus infection among solid organ transplant recipients in the United States

Cancer(2022)10.1002/cncr.34462Source: DataRank Database

Cancer risk associated with cytomegalovirus infection among solid organ transplant recipients in the United States is a research paper published in Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (79 grants)Impact (FWCI 2.79)OA: greenTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Logan G. Spector ORCID,Ruth M. Pfeiffer ORCID,Ajit P. Limaye ORCID,Kelly J. Yu ORCID,Eric A. Engels ORCID

Live enrichment

PubMed:36126024 PMC:PMC9633408 OpenAlex:https://openalex.org/W4296491878

National Institute of Allergy and Infectious Diseases

Grant: NIAID U0AI163090

National Institute of Allergy and Infectious Diseases

Grant: U0AI163090

National Institutes of Health

Grant: T32 AI083196

Fred Hutchinson Cancer Research Center

Grant: NU58DP006339‐05‐00

Centers for Disease Control and Prevention

Grant: NU58DP006320

Centers for Disease Control and Prevention

Grant: 5U58DP000824‐04

Centers for Disease Control and Prevention

Grant: NU58DP006288

Centers for Disease Control and Prevention

Grant: NU58DP006284

Centers for Disease Control and Prevention

Grant: NU58DP006317‐05‐01

Centers for Disease Control and Prevention

Grant: U58DP003933

Centers for Disease Control and Prevention

Grant: 6NU58DP006309

Centers for Disease Control and Prevention

Grant: HHSN26100001

Centers for Disease Control and Prevention

Grant: HHSN261201800014I

Centers for Disease Control and Prevention

Grant: 5NU58DP006279‐02‐00

Centers for Disease Control and Prevention

Grant: 5U58DP003921‐03

Centers for Disease Control and Prevention

Grant: 5U58DP003883‐03

Centers for Disease Control and Prevention

Grant: 1NU58DP006270

Centers for Disease Control and Prevention

Grant: 5U58DP003875‐01

Centers for Disease Control and Prevention

Grant: DP000848‐04

Centers for Disease Control and Prevention

Grant: DP000807‐01

Centers for Disease Control and Prevention

Grant: U58

National Cancer Institute

Grant: HHSN261201800016I

National Cancer Institute

Grant: N01‐PC‐35142

National Cancer Institute

Grant: HHSN261201800013I

National Cancer Institute

Grant: HHSN261201800012I

National Cancer Institute

Grant: N01‐PC‐35143

National Cancer Institute

Grant: HSN261201000032C

National Cancer Institute

Grant: HHSN261201800006I

National Cancer Institute

Grant: N01‐PC‐35139

National Cancer Institute

Grant: N01‐PC‐35137

National Cancer Institute

Grant: HHSN261201000037C

National Cancer Institute

Grant: HHSN261201800002I

National Cancer Institute

Grant: HHSN261201000034C

National Cancer Institute

Grant: HHSN261201000035C

National Cancer Institute

Grant: HHSN261201000036C

NHLBI NIH HHS

Grant: 75N92021D00009

NCI NIH HHS

Grant: HHSN261201800002B

NCI NIH HHS

Grant: N01 PC035143

NCCDPHP CDC HHS

Grant: U58 DP000807

NCCDPHP CDC HHS

Grant: U58 DP000848

NCCDPHP CDC HHS

Grant: U58 DP003883

NIH HHS

Grant: 75N98021D00006

CDC HHS

Grant: DP000807-01

CLC NIH HHS

Grant: 75N90021D00009

NIEHS NIH HHS

Grant: 75N96021D00006

NCI NIH HHS

Grant: HHSN261201800012C

NCI NIH HHS

Grant: HHSN261201800013C

NCI NIH HHS

Grant: HHSN261201800014C

NCI NIH HHS

Grant: N01-PC-35137

NCCDPHP CDC HHS

Grant: U58 DP000824

CDC HHS

Grant: 5U58DP003875-01

NIEHS NIH HHS

Grant: 75N96021D00009

NCI NIH HHS

Grant: HHSN261201000035I

NIAID NIH HHS

Grant: U01 AI163090

NIEHS NIH HHS

Grant: 27398C0011

CDC HHS

Grant: 5U58DP003883-03

NCI NIH HHS

Grant: N01-PC-35139

NCCDPHP CDC HHS

Grant: U58 DP003875

NIEHS NIH HHS

Grant: 27305C0011

NIEHS NIH HHS

Grant: 27307C0011

NHLBI NIH HHS

Grant: 75N92021D00006

NCI NIH HHS

Grant: N01 PC035142

NCI NIH HHS

Grant: N01-PC-35142

CDC HHS

Grant: 5U58DP003921-03

NCI NIH HHS

Grant: HHSN261201800002C

NCI NIH HHS

Grant: N01 PC035139

NCI NIH HHS

Grant: N01-PC-35143

NCCDPHP CDC HHS

Grant: U58 DP003921

CDC HHS

Grant: 5NU58DP006279-02-00

CDC HHS

Grant: 5U58DP000824-04

NLM NIH HHS

Grant: 75N97021D00006

ORFDO NIH HHS

Grant: 75N99021D00009

CDC HHS

Grant: DP000848-04

NCI NIH HHS

Grant: HHSN261201800016C

NCI NIH HHS

Grant: N01 PC035137

CDC HHS

Grant: NU58DP006317-05-01

University of Minnesota

Health Resources and Services Administration

National Cancer Institute

FWCI

2.79

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9633408

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9633408

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34462

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cncr.34462

publisherhttps://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34462

Fields of Study

Cytomegalovirus and herpesvirus researchViral-associated cancers and disordersRenal Transplantation Outcomes and TreatmentsHumansUnited StatesEpstein-Barr Virus InfectionsHerpesvirus 4, HumanCytomegalovirus InfectionsCytomegalovirusTransplant RecipientsOrgan TransplantationNeoplasmsAntiviral AgentsRetrospective Studies

MeSH Terms

Antiviral AgentsCytomegalovirus InfectionsCytomegalovirusHerpesvirus 4, HumanHumansNeoplasmsRetrospective StudiesUnited StatesOrgan TransplantationEpstein-Barr Virus InfectionsTransplant Recipients

Keywords

MedicineSerostatusInternal medicineIncidence (geometry)CytomegalovirusConfidence intervalGastroenterologyCancerImmunologyViral loadHerpesviridaeViral diseaseVirusLeukemiaLymphomaSolid TumorsSolid Organ TransplantationCytomegalovirus (Cmv)

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (6)

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

N/A

0.864DataRank · unranked

Nature Medicine(2022)

co-cited

10.1038/s41591-021-01623-z

Systemic immunity in cancer

N/A

1.1DataRank · unranked

Nature reviews. Cancer(2021)

co-cited

10.1038/s41568-021-00347-z

Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis

Gastroenterology(2021)

co-cited

10.1053/j.gastro.2021.06.025

Bystander T cells in cancer immunology and therapy

Nature Cancer(2022)

co-cited

10.1038/s43018-022-00335-8

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Cancer Cell(2023)

co-cited

10.1016/j.ccell.2023.08.013

After the Infection: A Survey of Pathogens and Non-communicable Human Disease

Top 72%

0.111DataRank

medRxiv(2023)

co-cited

10.1101/2023.09.14.23295428